Latest News
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?
Shares of biotech Intellia Therapeutics (NASDAQ: NTLA) are down by around 33% over the past 30 days, amid the publication of some new data from an early stage clinical trial on Nov. 16 and its third-quarter earnings on Nov. 7.Usually, updates like...
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
There's nothing bearish at all about what it reported recently.
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Maybe the Street is a bit too optimistic on this one.
12 High-Growth Stocks That Could Deliver Parabolic Returns
These 12 innovative companies could deliver exponential returns over the next quarter century.
Why Intellia Therapeutics Stock Plummeted by 20% Today
Seemingly encouraging results from the lab were met with some notable skepticism.
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
These stocks haven't performed well this year.
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
The Ark Invest portfolio is known for taking aggressive bets.
Promising clinical trial results have analysts optimistic about the company’s future.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth-stock investor added to these three existing positions on Wednesday.
The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger
An improbable but serious risk facing the company's investors just got minimized.
3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024
The popular growth investor is making big moves in July to bounce back after a rough start this year.
Investing can be tricky, especially in a dynamic market. To help you navigate the options, top analysts have highlighted several promising stocks for consideration on June 28th, 2024. Let’s explore three companies generating analyst interest: 1. United Airlines Holdings (UAL: NSD): The travel industry is seeing a strong rebound in...
All three are emerging players in their respective industries, with huge long-term potential.
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
These companies could generate explosive growth over time.
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
Neither word has anything to do with money -- at least not yet.